Skip to main content
Clinical Trials/NCT01481428
NCT01481428
Completed
Phase 1

Delivering HIV Risk Reduction Services in Treatment Court

Treatment Research Institute1 site in 1 country371 target enrollmentSeptember 2012

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Substance Abuse
Sponsor
Treatment Research Institute
Enrollment
371
Locations
1
Primary Endpoint
Engagement in high risk behaviors
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

This study will be the first to examine the efficacy of using a brief, computerized HIV risk reduction intervention in treatment courts.

Detailed Description

Four hundred consenting treatment drug court participants will be randomly assigned to either an HIV intervention group (n = 200) or an attention control group. All clients will attend their regularly scheduled status hearings which are scheduled approximately every six weeks. Clients in the HIV intervention group will receive a brief computerized, self-administered HIV risk reduction intervention following each of their first three status hearings. Clients in the attention control condition will view a series of educational life-skill videos of matched length following each of their first three status hearings. The primary outcome will be engagement in high risk behaviors as measured by the Risk Assessment Battery (RAB). Secondary HIV-related outcomes will include: (1) rate of HIV testing, (2) condom procurement, and (3) self-reported condom use. Tertiary outcomes related to treatment court compliance will include: (1) drug court graduation, (2) urinalysis-confirmed drug abstinence, (3) case management attendance, and (4) satisfaction with case management. In addition, we will conduct preliminary cost and cost-effectiveness analyses on the delivery of the brief computerized HIV intervention. Assessments will be conducted at baseline and 9- and 15-months post admission.

Registry
clinicaltrials.gov
Start Date
September 2012
End Date
December 2016
Last Updated
3 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Treatment Research Institute
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • be at least 18 years of age;
  • be charged with a non-violent felony offense
  • have no more than two prior non-violent convictions or diversionary opportunities
  • be willing to participate in the treatment court program for at least 12 months
  • be in need of treatment for substance abuse or dependence as assessed by case management.

Exclusion Criteria

  • Elderly subjects and those with medical problems will be included in the research as long as they do not have any physical or psychiatric condition that would impede their ability to give competent consent to research participation or to understand the research instruments.
  • Those individuals who are intoxicated, cognitively impaired, or psychiatrically unstable when approached will not be included; however, such individuals may subsequently be included if the disqualifying condition subsides.
  • Spanish speaking only individuals.
  • Client remanded to jail or residential treatment facilities at the time of Treatment Court enrollment.

Outcomes

Primary Outcomes

Engagement in high risk behaviors

Time Frame: 15 month follow-up

Measured by the Risk Assessment Battery (RAB)

Secondary Outcomes

  • Rate of HIV testing(15 month follow-up)
  • Self-reported Condom Use(15 month follow-up)
  • Condom Procurement(15 month follow-up)

Study Sites (1)

Loading locations...

Similar Trials